Cargando…
Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis
PURPOSE: High mobility group box 1 (HMGB1) contributes to poor disease outcome in Pseudomonas aeruginosa keratitis. This study tests the prophylactic effect of treatment with HMGB1 inhibitors, glycyrrhizin (GLY) and its derivative, carbenoxolone (CBX), for Pseudomonas keratitis. METHODS: We treated...
Autores principales: | Ekanayaka, Sandamali A., McClellan, Sharon A., Barrett, Ronald P., Kharotia, Shikhil, Hazlett, Linda D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089214/ https://www.ncbi.nlm.nih.gov/pubmed/27792814 http://dx.doi.org/10.1167/iovs.16-20103 |
Ejemplares similares
-
Decreasing HMGB1 levels improves outcome of Pseudomonas aeruginosa keratitis in mice
por: Hazlett, Linda D., et al.
Publicado: (2016) -
Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies
por: Hazlett, Linda D., et al.
Publicado: (2019) -
Characterization of Three Ocular Clinical Isolates of P. aeruginosa: Viability, Biofilm Formation, Adherence, Infectivity, and Effects of Glycyrrhizin
por: Peng, Xudong, et al.
Publicado: (2017) -
Glycyrrhizin Interacts with TLR4 and TLR9 to Resolve P. aeruginosa Keratitis
por: Somayajulu, Mallika, et al.
Publicado: (2022) -
Targeting Inflammation Driven by HMGB1 in Bacterial Keratitis—A Review
por: Hazlett, Linda D., et al.
Publicado: (2021)